Arkolith/Insider Trading/OKUR/Form 4

Leverone Jason A.

Chief Financial OfficerOnKure Therapeutics, Inc. (OKUR) · full profile →Form 4 · filed Apr 8, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$9K
Net Open-Market Flow
-$9K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 7, 2025Sell(S)2K$2.67$5K13K
Apr 4, 2025Sell(S)1K$3.33$4K15K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-010418) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML